Major clinical trial shows flucytosine a critical component of reducing deaths from cryptococcal meningitis

Posted by & filed under Uncategorized.

At the International AIDS Society conference in Paris today, Sile Molloy from St George‚Äôs Hospital Medical School in London presented the ACTA study results: the largest ever study of cryptococcal meningitis. 678 evaluable patients from 9 sites in 4 African countries were randomized into an all oral regimen of fluconazole (1200mg/d) and flycytosine (100mg/d), amphotericin… Read more »